跳至主要内容
临床试验/NCT01049347
NCT01049347已完成3 期

Hypothalamus-pituitary-adrenal System: Role of the Mineralocorticoid Receptor and Longitudinal Study in Depressed Patients

Central Institute of Mental Health, Mannheim1 个研究点 分布在 1 个国家目标入组 127 人开始时间: 1997年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
127
试验地点
1
主要终点
Hamilton Depression Rating Scale (21-item version)

研究概览

简要总结

Activation of the hypothalamus-pituitary-adrenal system is monitored using saliva cortisol sampling during the antidepressant treatment with amitriptyline and paroxetine in moderately to severely depressed patients. Additionally, serum and plasma are sampled during the 5-week study period in order to study endocrine and metabolic parameters.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age: above 18
  • depression according DSM-IV

排除标准

  • bipolar disorder
  • substance dependency

研究组 & 干预措施

amitriptyline

Active Comparator

干预措施: amitriptyline (Drug)

paroxetine

Active Comparator

干预措施: paroxetine (Drug)

结局指标

主要结局

Hamilton Depression Rating Scale (21-item version)

时间窗: baseline, weekly assessments for 5 weeks

次要结局

  • cortisol in saliva (8.00, 16.00, 22.00) during wash-out (6 days) and 35 days of treatment(daily during wash-out (days -6 to -1) and active treatment (days 1 to 35))

研究者

发起方
Central Institute of Mental Health, Mannheim
申办方类型
Other

研究点 (1)

Loading locations...

相似试验